ONCC's Oncology Certified Nurse
ONCC's Oncology Certified Nurse is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
ONCC's Oncology Certified Nurse is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
10 sample questions for the ONCC's Oncology Certified Nurse, with the correct answer and an explanation for each. No account needed. Try each one before you open the answer.
Sections covered on the exam: Care Continuum, Psychosocial Dimensions of Care, Oncology Nursing Practice, Treatment Modalities, Symptom Management and Palliative Care, Oncologic Emergencies.
Question 1 · Care Continuum
Answer: B. Primary prevention
Tobacco cessation removes exposure to a carcinogen before cancer develops, which is primary prevention. Secondary prevention is early detection through screening such as LDCT, and tertiary prevention limits disability or recurrence in people who already have cancer.
Question 2 · Oncology Nursing Practice
Answer: C. "Some damage is permanent, but quitting stops promotion and lowers your risk over time."
Initiation causes irreversible DNA damage, but promotion is reversible and depends on continued exposure, so stopping tobacco use lowers cancer risk over time. Quitting does not reverse initiating mutations. Risk does decline after cessation, and initiated cells do not inevitably progress to cancer.
Question 3 · Treatment Modalities
Answer: D. Pick it up with long-handled forceps and place it in the lead container
A dislodged sealed source is never handled by hand; the nurse uses long-handled forceps to place it in the lead container kept in the room, then notifies radiation safety. Gloves provide no shielding, sending linens to laundry spreads the hazard, and leaving the source exposed without containment increases exposure to others.
Question 4 · Symptom Management and Palliative Care
Answer: C. NK1 antagonist, 5-HT3 antagonist, dexamethasone and olanzapine
Cisplatin is highly emetogenic, and current guidelines recommend four-drug prophylaxis with an NK1 antagonist, a 5-HT3 antagonist, dexamethasone and olanzapine. A two-drug regimen suits moderate-risk agents, a single dopamine antagonist suits low-risk agents, and lorazepam is an adjunct for anticipatory nausea.
Question 5 · Oncologic Emergencies
Answer: A. IV crystalloid bolus of 30 mL/kg within the first 3 hours
Hypotension with a lactate of 4 mmol/L or higher indicates sepsis-induced hypoperfusion, and sepsis guidelines call for rapid IV crystalloid resuscitation of about 30 mL/kg within the first 3 hours, adding vasopressors if mean arterial pressure stays below 65 mm Hg. A diuretic worsens hypovolemia, red cell transfusion is not first-line resuscitation without severe anemia, and oral fluids are too slow and unreliable in shock.
Question 6 · Care Continuum
Answer: C. Two doses, because the series starts before age 15
A 2-dose HPV series is recommended when vaccination begins before the 15th birthday. Three doses are required when the series starts at 15 or older or in immunocompromised persons, and sexual activity does not change the number of doses.
Question 7 · Oncology Nursing Practice
Answer: B. Human herpesvirus 8
Kaposi sarcoma, which presents as violaceous skin and mucosal lesions in immunosuppressed patients, is caused by human herpesvirus 8. Epstein-Barr virus is linked to Burkitt and Hodgkin lymphoma and nasopharyngeal carcinoma, HPV to cervical and oropharyngeal cancers, and HTLV-1 to adult T-cell leukemia/lymphoma.
Question 8 · Treatment Modalities
Answer: B. "Yes. External beam radiation does not make your spouse radioactive."
External beam radiation is delivered from a machine outside the body and leaves no radioactive material in the patient, so no precautions are needed. Time and distance restrictions apply to temporary sealed implants and unsealed radiopharmaceuticals, not to external beam therapy.
Question 9 · Symptom Management and Palliative Care
Answer: D. Bone mineral density by DEXA scan
Aromatase inhibitors lower estrogen and accelerate bone loss, so a baseline DEXA scan with calcium, vitamin D and exercise counseling is recommended. Echocardiograms monitor anthracyclines and trastuzumab, DLCO monitors bleomycin, and audiograms monitor cisplatin.
Question 10 · Oncologic Emergencies
Answer: A. Cryoprecipitate
Cryoprecipitate is concentrated in fibrinogen, factor VIII and von Willebrand factor and is given when fibrinogen falls below about 150 mg/dL in a bleeding patient with DIC. Red cells replace oxygen-carrying capacity but not clotting factors, albumin is a volume expander with no hemostatic effect, and platelets correct thrombocytopenia rather than a low fibrinogen.
TTP Prep has 200 ONCC's Oncology Certified practice questions with explanations, timed and mock-exam modes, 181 flashcards, interactive lessons, a printable cheat sheet and a readiness score. Start free, no card needed.
More free questions: browse every exam.